SAPUPPO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.319
EU - Europa 998
AS - Asia 881
AF - Africa 111
SA - Sud America 102
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 1
Totale 3.447
Nazione #
US - Stati Uniti d'America 1.270
IT - Italia 394
SG - Singapore 368
RU - Federazione Russa 303
CN - Cina 275
BR - Brasile 78
KR - Corea 71
VN - Vietnam 66
CI - Costa d'Avorio 64
NL - Olanda 45
FR - Francia 39
SE - Svezia 37
IE - Irlanda 36
BD - Bangladesh 33
CA - Canada 31
DE - Germania 28
GB - Regno Unito 27
NG - Nigeria 19
IN - India 18
FI - Finlandia 17
HK - Hong Kong 12
PL - Polonia 10
AR - Argentina 9
CZ - Repubblica Ceca 9
ES - Italia 9
BJ - Benin 8
JP - Giappone 8
MX - Messico 8
UA - Ucraina 8
SN - Senegal 7
LT - Lituania 6
ZA - Sudafrica 6
AL - Albania 5
IQ - Iraq 5
CL - Cile 4
MD - Moldavia 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CO - Colombia 3
ID - Indonesia 3
JM - Giamaica 3
PK - Pakistan 3
PY - Paraguay 3
TR - Turchia 3
VE - Venezuela 3
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
GA - Gabon 2
GR - Grecia 2
MT - Malta 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
Totale 3.412
Città #
Singapore 253
Houston 172
Santa Clara 154
San Jose 153
Moscow 147
Dallas 141
Hefei 111
Chandler 81
Chicago 71
Seoul 71
Abidjan 64
Ashburn 58
Los Angeles 49
Beijing 44
Dublin 36
Rome 36
Civitanova Marche 35
Council Bluffs 34
Catania 28
Boardman 26
Buffalo 22
Lauterbourg 22
New York 20
Montreal 18
Ho Chi Minh City 17
Milan 15
Hong Kong 12
Amsterdam 11
Hanoi 11
Palermo 11
Abuja 10
Grafing 10
Naples 10
São Paulo 10
Lagos 9
Andover 8
Cambridge 8
Cotonou 8
Lappeenranta 8
Lawrence 8
Marseille 8
Munich 8
Tokyo 8
Warsaw 8
Bari 7
Chennai 7
Columbus 7
Dakar 7
Nanjing 7
Orem 7
Toronto 7
Aci Castello 6
Atlanta 6
Boston 6
Brno 6
Brooklyn 6
London 6
Phoenix 6
Turin 6
Bremen 5
Caserta 5
Charlotte 5
Da Nang 5
Denver 5
Florence 5
Genoa 5
Johannesburg 5
Misterbianco 5
Padova 5
Poplar 5
San Francisco 5
Stockholm 5
The Dalles 5
Frankfurt am Main 4
Haiphong 4
Helsinki 4
Jacksonville 4
Kochi 4
Modena 4
Reggio Emilia 4
Rio de Janeiro 4
Rose 4
Turku 4
Valledolmo 4
Wilmington 4
Acalanes Ridge 3
Bergamo 3
Bologna 3
Brussels 3
Can Tho 3
City of London 3
Des Moines 3
Guangzhou 3
Hebei 3
Kyiv 3
Madrid 3
Paris 3
Querétaro 3
Ragusa 3
Saint Petersburg 3
Totale 2.304
Nome #
Valore predittivo di recidiva/persistenza di malattia della VII e VIII edizione del sistema di stadiazione TNM e del sistema di stratificazione del rischio (2015 e 2009) dell'American Thyroid Association in una serie prospettica consecutiva di 451 pazienti con carcinoma differenziato tiroideo. Proposta di un nomogramma predittivo di recidiva o persistenza di malattia 298
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 295
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 172
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 159
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 150
Lymph node location is a risk factor for papillary thyroid cancer-related death 143
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 141
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 138
Orbital metastasis from thyroid cancer: a case report and review of the literature 132
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 130
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 123
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 121
Is multifocality a risk factor in low-risk papillary thyroid cancer? 118
Prognostic factors for adrenocortical carcinoma outcomes 116
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 110
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 110
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 110
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 105
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 105
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center 103
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 102
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 100
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 100
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 95
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 87
Gender Impact on Safety and Efficacy in Lenvatinib treated patients with radioiodine-refractory Differentiated Thyroid Cancer (GISEL study) 70
Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer 14
Totale 3.447
Categoria #
all - tutte 9.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 0 3 8 0 8 2 3 0 1 13
2022/2023191 9 12 3 35 12 25 5 36 40 0 5 9
2023/2024187 14 20 2 3 2 53 0 18 0 2 19 54
2024/2025748 15 100 57 59 115 98 32 34 27 64 70 77
2025/20261.953 134 187 212 134 248 401 184 44 154 100 103 52
2026/202791 28 60 3 0 0 0 0 0 0 0 0 0
Totale 3.447